Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
| Brand name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Generic name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Active ingredient(s) | AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL |
| Distributed by / for | Ascend Laboratories, LLC., Parsippany, NJ 07054 |
| NDC | 67877-501-30 |
| Full product label | Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30. |
| Recalling firm | Ascend Laboratories, LLC |
| Distribution | U.S.A. Nationwide |
| Quantity | 15,696 x 30's bottles |
| Recall initiated | 2026-05-05 |
| Report date | 2026-06-10 |
| Recall completed | — |
| Recall number | D-0556-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bedminster NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗